Literature DB >> 1697872

Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study.

P Van Eyken1, R Sciot, V J Desmet.   

Abstract

The novel extracellular matrix glycoprotein tenascin was studied immunohistochemically in normal and fibrotic human liver. Its localization was compared to that of laminin, fibronectin and collagen type IV. In the normal liver, a weak staining for tenascin was detected along sinusoids, while portal tracts were negative. In both alcoholic and cholestatic liver disease and acute and chronic hepatitis, sinusoidal immunoreactivity for tenascin was variably increased as compared to the normal liver. Most striking, however, was the preferential accumulation of tenascin at connective tissue-parenchymal interfaces between proliferating ductules and in areas of piecemeal necrosis. As compared to laminin, fibronectin and collagen type IV, tenascin has the most restricted distribution. Our findings indicate that tenascin is a component of the extracellular matrix of the human liver. Its preferential expression at connective tissue-parenchymal interfaces in fibrosing areas in contrast to its absence from mature fibrous septa suggest a transient role in early matrix organization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697872     DOI: 10.1016/0168-8278(90)90270-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

2.  Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells.

Authors:  Yunhong Nong; Dongbo Wu; Yong Lin; Yongqiang Zhang; Lang Bai; Hong Tang
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 3.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 4.  The hepatic extracellular matrix. I. Components and distribution in normal liver.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 5.  The lymphatics of the liver.

Authors:  M Trutmann; D Sasse
Journal:  Anat Embryol (Berl)       Date:  1994-09

6.  Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience.

Authors:  G L Davis
Journal:  Gut       Date:  1993       Impact factor: 23.059

Review 7.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

8.  Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues.

Authors:  M Chilosi; M Lestani; A Benedetti; L Montagna; S Pedron; A Scarpa; F Menestrina; S Hirohashi; G Pizzolo; G Semenzato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury.

Authors:  J E Hines; S J Johnson; A D Burt
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

10.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.